SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-141736
Filing Date
2004-08-16
Accepted
2004-08-16 15:51:00
Documents
7
Period of Report
2004-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 709934
2 SUBSIDIARIES OF THE REGISTRANT NEOGEN CORPORATION AND SUBSIDIARIES dex21.htm EX-21 6716
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ERNST $ YOUNG LLP dex23a.htm EX-23.A 1723
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM DELOITTE & TOUCHE LLP dex23b.htm EX-23.B 1531
5 SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 8582
6 SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 8593
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 4788
  Complete submission text file 0001193125-04-141736.txt   744282
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 04978643
SIC: 2835 In Vitro & In Vivo Diagnostic Substances